Top-Ranked Growth Stocks to Buy Now for March

Top 3 Growth Stocks to Invest in this March

Growth stocks have recovered their footing in early 2023 after a challenging 2022. The iShares Russell 1000 Growth ETF has tracked higher by 7% over this time frame, while the Vanguard Growth Index Fund is up a respectable 8.8% so far this year. Through the first two months of 2023, both of these growth bellwether indices beat the benchmark S&P 500.

Which equities are poised to profit most from this pattern reversal among growth stocks? Stocks that are rising on the strength of stronger foundations are always worth looking into. Following a significant shift to their core narrative, these three growth-oriented businesses are starting to heat up.

Sarepta Therapeutics

Sarepta Therapeutics (SRPT 19.24%) specializes in treating uncommon diseases. Currently, the business has three Duchenne muscular dystrophy (DMD) treatments that have received FDA approval in the United States (DMD). Due to the potential for a fourth FDA clearance, shares of Sarepta have increased by 59% over the last year. SRP-9001 is anticipated to be approved by the FDA for the therapy of ambulant DMD patients on May 29, 2023.

Best March Growth Stock Picks for Investors
March’s Hottest Growth Stocks for Investment

The big issue is what? This Roche-partnered drug, in Sarepta’s estimation, could reach peak revenues of upwards of $4 billion. Additionally, this indication has been demonstrated to have a very high entry barrier, with almost every experimental therapy failing in clinical trials. As a result, SRP-9001 has a built-in competitive moat and an extremely high business ceiling. According to bullish analysts, this biotech company still has 53% more room for growth.

Hims & Hers Health

An uncommon healthcare provider is Hims & Hers Health (HIMS 2.31%). Patients are linked up with qualified healthcare experts through its multi-speciality telehealth platform. Patients can obtain prescription treatments through the Hims & Hers Health digital portal for a variety of ailments, including sexual health, hair loss, dermatology, mental health, and primary care.

Also Read:  Gianna Christine: Net Worth and Human Thinking.

Hims & Hers Health has been rapidly gaining market share lately, despite the fact that the company’s cloud-based telehealth business strategy is by no means original. The company’s subscriber base has grown by 190% over the last two years, leading to a more than quadrupling of its annual web revenues during this time. Through its distinctive marketing campaign focusing on taboo conditions like sexual health and hair loss, Hims & Hers Health has been able to take market share away from established rivals.

The rising fundamentals of Hims & Hers Health have had a significant positive impact on the market price. The stock price of the business has soared by an impressive 120% in the last 12 months.

However, this speciality healthcare stock should have a lot more opportunity to grow in the years to come. In fact, Hims & Hers Health has only begun to penetrate the vast potential market.

MercadoLibre

South America‘s largest online retailer is MercadoLibre (MELI -0.93%). To draw new users to its platform and then keep them there, the company has also developed a fintech ecosystem that is quickly expanding. Along with other e-retailers, the company’s stock declined in 2022. But since the start of 2023, the equity price of MercadoLibre has increased by about 42%.

Why the sudden change in direction? The ongoing growth of e-commerce across Latin America presents significant business potential for MercadoLibre. Additionally, the business has developed a strong competitive advantage with the launch of its best-in-class shipping service, Mercado Envios, and integrated digital payments platform, Mercado Pago.

Also Read:  Liliana Mumy Net Worth: Discover How Much the Human Thinking Star Is Worth.

As a result, MercadoLibre should keep gaining market dominance quickly and fend off any potential rivals. The e-commerce behemoth’s long-term prospects appear promising thanks to that potent combination.

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Prev
UK interest rates may keep rising, says Bank of England boss
UK interest rates could continue to climb, warns Bank of England

UK interest rates may keep rising, says Bank of England boss

Andrew Bailey, the head of the Bank of England, has suggested that interest

Next
Tesla announces new factory in Mexico
Tesla Set to Establish Presence in Mexico with New Factory Announcement

Tesla announces new factory in Mexico

In the next few years, Tesla will join other automakers in expanding their

You May Also Like